000 | 01928 a2200529 4500 | ||
---|---|---|---|
005 | 20250517215930.0 | ||
264 | 0 | _c20190806 | |
008 | 201908s 0 0 eng d | ||
022 | _a1478-3231 | ||
024 | 7 |
_a10.1111/liv.13887 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHu, Ming-Hung | |
245 | 0 | 0 |
_aSerine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma. _h[electronic resource] |
260 |
_bLiver international : official journal of the International Association for the Study of the Liver _c12 2018 |
||
300 |
_a2248-2259 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAMP-Activated Protein Kinases _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 | _aApoptosis |
650 | 0 | 4 |
_aBile Duct Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aCantharidin _xpharmacology |
650 | 0 | 4 | _aCarcinogenesis |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aCell Proliferation |
650 | 0 | 4 | _aCell Survival |
650 | 0 | 4 |
_aCholangiocarcinoma _xdrug therapy |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 |
_aNuclear Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aPhosphoprotein Phosphatases _xantagonists & inhibitors |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aHuang, Tzu-Ting | |
700 | 1 | _aChao, Tzu-I | |
700 | 1 | _aChen, Li-Ju | |
700 | 1 | _aChen, Yen-Lin | |
700 | 1 | _aTsai, Ming-Hsien | |
700 | 1 | _aLiu, Chun-Yu | |
700 | 1 | _aKao, Jia-Horng | |
700 | 1 | _aChen, Kuen-Feng | |
773 | 0 |
_tLiver international : official journal of the International Association for the Study of the Liver _gvol. 38 _gno. 12 _gp. 2248-2259 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/liv.13887 _zAvailable from publisher's website |
999 |
_c28426506 _d28426506 |